Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI–PARP–Radioligand Era

Takatoshi Somoto, Takanobu Utsumi, Rino Ikeda, Tatsuharu Sugimoto, Naoki Ishitsuka, Yodai Kadono, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Ryo Oka, Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki · 2026

Read Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI–PARP–Radioligand Era by Takatoshi Somoto, Takanobu Utsumi, Rino Ikeda, Tatsuharu Sugimoto, Naoki Ishitsuka, Yodai Kadono, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Ryo Oka, Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13297381.txt.

Description

Metastatic prostate cancer care now favors early drug combinations over hormone treatment alone, and Takatoshi Somoto with co-authors mapped that shift in a 2026 review. Their account follows how landmark trials reshaped management of hormone-sensitive and castration-resistant disease.

Readers get guidance on who gains from upfront intensification, why DNA repair testing belongs early in the pathway, and how PSMA PET scans flag candidates for targeted radioligand therapy. The authors also explain why one androgen receptor blocker can blunt response to the next, citing receptor reactivation, lineage change, and uneven PSMA expression. Practical sequencing advice weighs blood reserve, other illnesses, and local access to monitoring.

Catalog record

CREATORTakatoshi Somoto, Takanobu Utsumi, Rino Ikeda, Tatsuharu Sugimoto, Naoki Ishitsuka, Yodai Kadono, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Ryo Oka, Takumi Endo, Naoto Kamiya, Hiroyoshi Suzuki
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39083
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13297381

Browse the full library · About the Tower of Babel